Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Environmental Toxicology|August 26, 2015
Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatmentCheng-Huang Shen, Tien-Huang Lin, You-Liang Hsieh, et al.
Journal of Pineal Research|February 17, 2022
Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α2 β1 expressionHuai-Ching Tai, Shih-Wei Wang, Sanskruti Swain, et al.
Anticancer Research|May 13, 2015
Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial CancerWen-Shin Chang, Cheng-Hsi Liao, Chin-Mu Hsu, et al.
Anticancer Research|December 30, 2022
Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer RiskCheng-Hsi Liao, Wen-Shin Chang, Wei-Lin Hsu, et al.
The Kaohsiung Journal of Medical Sciences|July 26, 2018
Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10 ng/mLPo-Fan Hsieh, Chao-Hsiang Chang, Chi-Rei Yang, et al.
Therapeutic Advances in Urology|February 16, 2026
Contralateral recurrent upper-tract urothelial carcinoma after curative surgery: a multicentre retrospective cohort studyYao-Lin Kao, I-Hsuan Alan Chen, Chia-Cheng Yu, et al.
Cells|October 27, 2022
Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p ExpressionTien-Huang Lin, Sunny Li-Yun Chang, Pham Minh Khanh, et al.
Cancers|July 14, 2023
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective StudyHao Xiang Chen, Li-Hsien Tsai, Chao-Hsiang Chang, et al.
Journal of Hematology & Oncology|May 24, 2018
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trialJun Guo, Jie Jin, Mototsugu Oya, et al.
European Urology|November 7, 2018
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian SettingsPeter K-F Chiu, Chi-Fai Ng, Axel Semjonow, et al.
Pageof 18